Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 829-35-6 | MDL No. : | MFCD00491615 |
Formula : | C9H8N2O2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | GYESXRJGLIKNAM-UHFFFAOYSA-N |
M.W : | 176.17 | Pubchem ID : | 766687 |
Synonyms : |
|
Num. heavy atoms : | 13 |
Num. arom. heavy atoms : | 11 |
Fraction Csp3 : | 0.11 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 46.23 |
TPSA : | 48.15 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.47 cm/s |
Log Po/w (iLOGP) : | 2.08 |
Log Po/w (XLOGP3) : | 1.28 |
Log Po/w (WLOGP) : | 1.75 |
Log Po/w (MLOGP) : | 1.08 |
Log Po/w (SILICOS-IT) : | 1.9 |
Consensus Log Po/w : | 1.62 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.23 |
Solubility : | 1.03 mg/ml ; 0.00585 mol/l |
Class : | Soluble |
Log S (Ali) : | -1.89 |
Solubility : | 2.27 mg/ml ; 0.0129 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -3.51 |
Solubility : | 0.0547 mg/ml ; 0.00031 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.92 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
100% | With ammonium chloride In ethanol for 0.5 h; Reflux | General procedure: To asolution of hydrazide (0.73 mmol) in 10 mL of anhydrous ethanol, added triethyl orthoester (0.81 mmol) and ammonium chloride (0.219 mmol). The solution was stirred and heated to reflux until it complete (0.5-18 h). The reaction mass was cooled to room temperature and concentrated under vacuum. The crude product was made into slurry in a mixture of hexanes and ether (3:1), filtered,washed with deionized water or purified by column chromatography. |
92% | at 100 - 110℃; for 12 h; | To a mixture of 3 (18.0 g, 0.1083 mol) and triethyl orthoformate (80.3 g, 0.541 mol) was heated to 100-110 °C and maintained for 12 h. The reaction completion was monitored by TLC. The reaction mixture was cooled to room temperature and concentrated to syrup. Traces triethyl orthoformate was removed by azeotropic distillation with toluene. The residue was purified by column chromatography on silica gel using eluent 0-5percent ethyl acetate in petroleum ether. The title compound was yielded as pale yellow liquid (Yield: 17.55 g, 92percent). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
67% | With trifluoroacetic acid In toluene at 130℃; for 12 h; | General procedure: A 25 mL pressure tube was charged with arylhydrazide 1 (0.5 mmol), TFBen (53 mg, 0.25 mmol, white solid, mp 57.2-58.5 °C), TFA (38 μL, 1.0 equiv), and toluene (4 mL). The tube was then heated by stirring the contents at 130 °C for 12 h. Afterwards, the mixture was cooled to r.t., quenched with sat. aq NaHCO3 (3 mL), and extracted with EtOAc (3 4 mL). The combined organic layers were dried (anhyd Na2SO4), filtered, and concentrated under reduced pressure. The pure product 2 was obtained after purification by column chromatography (EtOAc/ pentane 1:3). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
96% | With Al3+-K10 montmorillonite clay In neat (no solvent) at 55℃; for 0.25 h; Microwave irradiation | General procedure: A 5 mL microwave vial was charged with acidhydrazide (100 mg, 1 eq), trimethyl orthoester (2 eq) and Al3+-K10 clay (75 mg). The resulting mixture was kept under microwave irradiation maintaining the temperature at 55 °C for 15 min (Microwave irradiations were performed on CEM-discover model No. 908010). The reaction was monitored by TLC. After completion of the reaction, reaction mixture was diluted with ethyl acetate stirred well, filtered, washed well with ethyl acetate. Filtrate was evaporated under reduced pressure to obtain highly pure product. In some cases, products were purified by column chromatography using 60-120 mesh silica with 20-100 percent ethyl acetate in pet ether as eluting solvents. The catalyst recovered by filtration was reused for another 5 more times. |
[ 51039-53-3 ]
2-Bromo-5-phenyl-1,3,4-oxadiazole
Similarity: 0.77
[ 99367-44-9 ]
Ethyl 5-(4-methoxyphenyl)-1,3,4-oxadiazole-2-carboxylate
Similarity: 0.76
[ 1483-31-4 ]
2-Chloro-5-phenyl-1,3,4-oxadiazole
Similarity: 0.73
[ 1612-76-6 ]
5-Phenyl-1,3,4-oxadiazol-2-amine
Similarity: 0.73
[ 959-36-4 ]
2,2'-(Hydrazine-1,2-diylidenebis(methanylylidene))diphenol
Similarity: 0.67
[ 99367-44-9 ]
Ethyl 5-(4-methoxyphenyl)-1,3,4-oxadiazole-2-carboxylate
Similarity: 0.76
[ 91063-19-3 ]
3-(Benzyloxy)-6-chloropyridazine
Similarity: 0.62
[ 121041-41-6 ]
6-(4-Methoxyphenoxy)pyridazin-3-amine
Similarity: 0.61
[ 51039-53-3 ]
2-Bromo-5-phenyl-1,3,4-oxadiazole
Similarity: 0.77
[ 99367-44-9 ]
Ethyl 5-(4-methoxyphenyl)-1,3,4-oxadiazole-2-carboxylate
Similarity: 0.76
[ 1483-31-4 ]
2-Chloro-5-phenyl-1,3,4-oxadiazole
Similarity: 0.73
[ 1612-76-6 ]
5-Phenyl-1,3,4-oxadiazol-2-amine
Similarity: 0.73
[ 3004-42-0 ]
5-Phenyl-1,3,4-oxadiazole-2(3H)-thione
Similarity: 0.57